Source - RNS
RNS Number : 3939L
Byotrol PLC
30 September 2016


30 September 2016


Byotrol plc


("Byotrol" or the "Company")


Result of Noteholders meeting

Further to the announcement on 9 September 2016, the Company is pleased to announce that at the Noteholders' meeting, held earlier today, the resolution to amend certain terms of the Loan Notes issued to the Noteholders on 20 December 2013 was duly approved.

Specifically, it was proposed that the Noteholders agree to rollover the maturity of the Loan Notes, which was originally set at three years, being the 20 December 2016. Pursuant to the meeting today, it has been agreed that the Loan Notes be extended by a further two years, resulting in a total term of the Loan Notes of five years. All other terms remain the same.


Byotrol plc

01925 742 000

David Traynor - Chief Executive


finnCap Ltd

020 7220 0500

(Nominated Adviser & Broker)

Geoff Nash/Carl Holmes/James Thompson - Corporate Finance

Mia Gardner - Corporate Broking


Notes to Editors:


Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial technologies.

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens


Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.


For more information, please go to



This information is provided by RNS
The company news service from the London Stock Exchange